0 CHECKOUT

Global Personalized Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

  • ID: 2300222
  • April 2016
  • Region: Global
  • 891 Pages
  • CurrentPartnering
1 of 4

The Global Personalized Medicine Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest Personalized Medicine agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Personalized Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Personalized Medicine partnering deals.

The report presents financial deal term values for Personalized Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Personalized Medicine partnering field; both the leading deal values and most active Personalized Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of READ MORE >

Note: Product cover images may vary from those shown
2 of 4

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Personalized Medicine dealmaking

2.1. Introduction
2.2. Personalized Medicine partnering over the years
2.3. Most active Personalized Medicine dealmakers
2.4. Personalized Medicine partnering by deal type
2.5. Personalized Medicine partnering by therapy area
2.6. Deal terms for Personalized Medicine partnering
2.6.1 Personalized Medicine partnering headline values
2.6.2 Personalized Medicine deal upfront payments7
2.6.3 Personalized Medicine deal milestone payments
2.6.4 Personalized Medicine royalty rates

Chapter 3 - Leading Personalized Medicine deals

3.1. Introduction
3.2. Top Personalized Medicine deals by value

Chapter 4 - Most active Personalized Medicine dealmakers

4.1. Introduction
4.2. Most active Personalized Medicine dealmakers
4.3. Most active Personalized Medicine partnering company profiles

Chapter 5 - Personalized Medicine contracts dealmaking directory

5.1. Introduction
5.2. Personalized Medicine contracts dealmaking directory

Chapter 6 - Personalized Medicine dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Personalized Medicine deals by company A-Z

Appendix 2 - Personalized Medicine deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 - Personalized Medicine deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 - Personalized Medicine deals by therapy area

Appendix 5 -Deal type definitions

About

Recent report titles

Table of figures

Figure 1: Personalized Medicine partnering since 2010
Figure 2: Active Personalized Medicine dealmaking activity- 2010 to 2016
Figure 3: Personalized Medicine partnering by deal type since 2010
Figure 4: Personalized Medicine partnering by disease type since 2010
Figure 5: Personalized Medicine deals with a headline value
Figure 6: Personalized Medicine deals with an upfront value
Figure 7: Personalized Medicine deals with a milestone value
Figure 8: Personalized Medicine deals with a royalty rate value
Figure 9: Top Personalized Medicine deals by value since 2010
Figure 10: Most active Personalized Medicine dealmakers 2010 to 2016
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Note: Product cover images may vary from those shown
3 of 4

Personalized Medicine Partnering 2010-2015 provides the reader with the following key benefits:

- In-depth understanding of Personalized Medicine deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Personalized Medicine agreements with numerous real life case studies
- Detailed access to actual Personalized Medicine contracts entered into by leading biopharma companies
- Identify most active Personalized Medicine dealmakers since 2010
- Insight into terms included in a Personalized Medicine partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

  • Quick Help: A copy of the report will be emailed to you and a copy will be shipped to you in CD ROM format. The Electronic copy is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Beckman Coulter, Inc.
  • Luminex Corporation
  • Quest Diagnostics, Inc.
  • Qiagen N.V.
  • Affymetrix, Inc.
  • Roche Diagnostics Ltd.